Wikidata

(Q33493361)

English

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

scientific article

In more languages

Statements

title
Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8275479
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8275479%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33493361&oldid=1644423662"